Yongqing Dong | Genetic Diseases | Best Researcher Award

Assoc. Prof. Dr. Yongqing Dong | Genetic Diseases | Best Researcher Award

Tianjin University | China

Author Profile

Scopus

Orcid ID

šŸ“– BIOGRAPHY OF YONGQING DONG

šŸŽ“ EARLY ACADEMIC PURSUITS

Yongqing Dongā€™s academic journey began with a focus on social development and public policy, eventually expanding into interdisciplinary fields like labor migration, child development, and health care. His commitment to understanding social dynamics in rural and urban China has laid the groundwork for his distinguished career.

šŸ’¼ PROFESSIONAL ENDEAVORS

  • 2023ā€“Present: Associate Professor, College of Management and Economics, Tianjin University
  • 2018ā€“2023: Assistant Professor, College of Management and Economics, Tianjin University

Dong has cultivated an academic environment that merges policy analysis with real-world applications, fostering innovation and practical solutions to societal challenges.

šŸ”¬ CONTRIBUTIONS AND RESEARCH FOCUS ON GENETIC DISEASES

Yongqing Dong's research investigates pressing social issues, such as the effects of labor migration on childrenā€™s development and healthcare accessibility. His research areas include:

  • Primary Focus: Social development and public policy
  • Secondary Focus:
    • Labor migration and its societal impacts
    • Child development in rural and urban settings
    • Innovations in healthcare systems

His landmark study, "The Long-Term Effect of Parental Migration on the Human Capital Accumulation of Children: Evidence from Rural China," supported by the Humanity and Social Science Youth Foundation of the Ministry of Education of China, underscores his dedication to advancing public knowledge.

šŸŒ IMPACT AND INFLUENCE

Dong's insights into labor migration and its influence on family dynamics have shaped discussions among policymakers and scholars. His work on child development provides critical perspectives for improving education and healthcare systems, particularly in rural China.

šŸ“š ACADEMIC CITATIONS

Yongqing Dongā€™s scholarship has been recognized in highly regarded journals, including:

  • Social Forces
  • China Economic Review
  • Journal of Family Studies
  • Economic Analysis and Policy

Additionally, he contributes as a referee to prominent journals, influencing academic discourse on economics and public health.

šŸ… LEGACY AND FUTURE CONTRIBUTIONS

As an active member of professional associations like the Agricultural & Applied Economics Association (China Section) and the Chinese Economist Society, Yongqing Dong is at the forefront of economic and policy research. His future endeavors will likely further explore how social policies can mitigate inequalities and foster development in underprivileged regions.

Through teaching, mentorship, and groundbreaking research, Dong is shaping the next generation of policymakers and scholars.

šŸ—£ļø LANGUAGES

  • English: Professional working proficiency
  • Mandarin: Native

This biography celebrates Yongqing Dong's commitment to addressing the complexities of societal development through rigorous research and impactful teaching. šŸŒŸ

šŸ“‘Ā NOTABLE PUBLICATIONSĀ 

"The Divergence of Inequality in Healthcare Utilization Between Poor- and Rich-Medical Resource Regions: Evidence from the Middle-Aged and Older Adults in China"Ā 

  • Authors: Fang, Y. , Fu, L. , Xu, Y. , Dong, Y.
  • Journal: Social Indicators Research
  • Year: 2024

"Mediating Effects of Information Access on Internet Use and Multidimensional Health Among Middle-Aged and Older Adults: Nationwide Cross-Sectional Study"Ā 

  • Authors: Fu, L. , Liu, C. , Dong, Y. , Li, D. , Di, K.
  • Journal: Journal of Medical Internet Research
  • Year: 2024

"How does information and communication technology promote tourism development? Evidence from the e-commerce pilot city policy in China"Ā 

  • Authors: Fu, L. , Yang, J. , Dong, Y. , Pei, T.
  • Journal: Tourism Economics
  • Year: 2024

"The healthcare inequality among middle-aged and older adults in China: a comparative analysis between the full samples and the homogeneous population"Ā 

  • Authors: Fu, L. , Fang, Y. , Dong, Y.
  • Journal: Health Economics Review
  • Year: 2022

"The Health Inequality of Children in China: A Regression-Based Decomposition Analysis"Ā 

  • Authors: Dong, Y. , Deng, Q. , Li, S.
  • Journal: Child Indicators Research
  • Year: 2022

Paritha Arumugam | Gene Therapy | Best Researcher Award

Dr. Paritha Arumugam | Gene Therapy | Best Researcher Award

Cincinnati Children's Hospital Medical Center | United States

AUTHOR PROFILE

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS

Paritha Arumugam's academic journey began at the University of Madras, Bharathi Women's College, where she earned her B.Sc. in Biochemistry in 1991. She continued her education at the University of Madras, Guindy Campus, obtaining her M.Sc. in Biochemistry in 1993, M.Phil. in Biochemistry in 1994, and Ph.D. in Biochemistry in 1998 under the mentorship of Shyamala Devi, C.S. Her academic excellence was recognized with numerous awards, including the Gold Medal for securing the first rank in her M.Sc. program and various other prestigious prizes from the University of Madras.

PROFESSIONAL ENDEAVORS

Dr. Arumugam's professional career is marked by significant roles in both academic and research settings. She served as a Postdoctoral Research Fellow at the Childrenā€™s Hospital Los Angeles (CHLA) from 2004 to 2006, under the guidance of Dr. Punam Malik in the Division of Hematology-Oncology. She later earned an M.S. in Drug Development from the University of Cincinnati in 2011, where she was advised by Kevin L. Skare.Ā Her academic appointments at the University of Cincinnati College of Medicine and Cincinnati Childrenā€™s Hospital Medical Center (CCHMC) have been pivotal. She progressed from Research Instructor in Pediatrics (2015-2019) to her current position as an Assistant Professor in Pediatrics at the Translational Pulmonary Science Center, Division of Pulmonary Biology, beginning in October 2019.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE THERAPY

Dr. Arumugam's research has significantly advanced the fields of biochemistry and molecular biology, with a particular focus on translational pulmonary science. Her work on developing a novel cell transplantation therapy, specifically Pulmonary Macrophage Transplantation, earned her a plenary talk at the NHLBI Celebration of 15 Years of Basic and Translational Progenitor Cell Research in 2023. Her research has garnered numerous awards, including the Excellence in Hemoglobinopathy Research Award from the National Institutes of Health and multiple abstract and travel awards from the American Society of Hematology.

IMPACT AND INFLUENCE

Dr. Arumugam's impact extends beyond her direct research contributions. Her role in advancing clinical practices is underscored by her licensing and certification in Good Clinical Practice for clinical trials involving drugs and devices. Her expertise in conducting investigator-initiated studies according to FDA regulations and GCP has positioned her as a leader in the field, capable of managing investigational agents and overseeing the ethical conduct of clinical trials.

ACADEMIC CITES

Dr. Arumugam's academic excellence has been recognized with several citations and awards throughout her career. Notably, she has been a recipient of the Cincinnati Childrenā€™s Innovation Excellence Award in 2023 and the NHLBI Celebration of 15 Years of Basic and Translational Progenitor Cell Research Poster Award. Her scholarly contributions are also highlighted by her selection as a Translational Sickle Scholar by the National Institutes of Health.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Arumugam's legacy is defined by her dedication to advancing medical science and improving clinical practices. Her pioneering research on pulmonary macrophage transplantation and her contributions to hemoglobinopathy research underscore her commitment to translational science. Looking forward, Dr. Arumugam aims to continue her impactful research, mentor the next generation of scientists, and contribute to significant advancements in pediatric pulmonary biology and therapeutic developments.

NOTABLE PUBLICATIONS